CLEC4A and colorectal carcinoma: We confirmed that CLEC4A was a marker of favorable prognostic in CRC patients by reanalyzing the transcriptomic TCGA data from 694 CRC patient samples as well as by using an independent cohort of 579 CRC samples (Fig. 1B,C)31.